19
Vivus, based in U.S.A, is a pharmaceutical company.
One of their notable products is PANCRELIPASE (AMYLASE;LIPASE;PROTEASE), with a corresponding application number 22523.
With a dosage strength 149,900USP UNITS; 37,000USP UNITS; 97,300USP UNITS
Dosage Form Route CAPSULE, DELAYED RELEASE; ORAL
18
Vivus, based in U.S.A, is a pharmaceutical company.
One of their notable products is PANCRELIPASE (AMYLASE;LIPASE;PROTEASE), with a corresponding application number 22523.
With a dosage strength 98,400USP UNITS; 16,800USP UNITS; 56,800USP UNITS
Dosage Form Route CAPSULE, DELAYED RELEASE; ORAL
17
Vivus, based in U.S.A, is a pharmaceutical company.
One of their notable products is PANCRELIPASE (AMYLASE;LIPASE;PROTEASE), with a corresponding application number 22523.
With a dosage strength 24,600USP UNITS; 4,200USP UNITS; 14,200USP UNITS
Dosage Form Route CAPSULE, DELAYED RELEASE; ORAL
16
Vivus, based in U.S.A, is a pharmaceutical company.
One of their notable products is PANCRELIPASE (AMYLASE;LIPASE;PROTEASE), with a corresponding application number 22523.
With a dosage strength 15,200USP UNITS; 2,600USP UNITS; 8,800USP UNITS
Dosage Form Route CAPSULE, DELAYED RELEASE; ORAL
15
Vivus, based in U.S.A, is a pharmaceutical company.
One of their notable products is PANCRELIPASE (AMYLASE;LIPASE;PROTEASE), with a corresponding application number 22523.
With a dosage strength 83,900USP UNITS; 21,000USP UNITS; 54,700USP UNITS
Dosage Form Route CAPSULE, DELAYED RELEASE; ORAL
14
Vivus, based in U.S.A, is a pharmaceutical company.
One of their notable products is PANCRELIPASE (AMYLASE;LIPASE;PROTEASE), with a corresponding application number 22523.
With a dosage strength 61,500USP UNITS; 10,500USP UNITS; 35,500USP UNITS
Dosage Form Route CAPSULE, DELAYED RELEASE; ORAL